scorecardresearch
Tuesday, August 26, 2025
TopicAntibiotics

Topic: antibiotics

Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.

All about nafithromycin, first antibiotic developed in India against deadly, drug-resistant bacteria

Developed by Mumbai-based Wockhardt, it will be available under brand name Miqnaf. Administering it once-a-day for 3 days could be significant in addressing drug-resistant pneumonia.

Drug regulator considers making central nod mandatory for all antibiotics in India, even existing ones

This new proposal, being considered by CDSCO, comes in response to concerns over antimicrobial resistance emerging as a massive public health challenge across the globe, including in India.

More people dying from lack of access to antibiotics. It is leading to rise in drug resistance

By 2050, the total number of deaths associated with drug resistance are expected to reach a staggering 169 million.

Up to 10.4 lakh deaths in India in 2019 due to antibiotic-resistant superbugs, says Lancet report

Findings published Tuesday also said that over 39 crore deaths caused directly or indirectly by antibiotic-resistant infections are estimated to occur worldwide by 2050.

In a 1st, ICMR to build algorithms for antibiotic use in common illnesses to curb misuse

ICMR is working on guidelines on empirical use of antibiotics. Misuse of empirical antibiotics leads to antimicrobial resistance, a major public health challenge in India.

‘Dawn of new era in medicine’ — AI helps scientists develop safe form of antibiotic produced by pigs

AI was used to modify Protegrin-1, an antibiotic found in pigs, to be safe for humans. Development has huge potential for tackling antimicrobial resistance, say microbiologists.

Cheap alternatives, API imports — why Penicillin G production, set to resume after 30 yrs, declined

Production of PenG, used to treat tetanus, strep infections, syphilis, pneumonia & more, was stopped in India in 1990s after cheaper alternatives began surfacing in global market.

Antibiotic prescriptions should mention reason, govt tells doctors amid alarm over drug resistance

In a letter sent earlier this month, Union government has also urged pharmacists to stop selling antibiotics over the counter, without a valid prescription from a doctor.

Ceftriaxone, among India’s most prescribed antibiotics, ‘increasingly resistant’ against pathogens

Monocef, a popular brand of the drug, has been among top-selling medicines these last few months. Ceftriaxone is ‘watch’ antibiotic, with high potential for antimicrobial resistance. 

On Camera

India will absorb Trump tariff impact due to its Achilles’ heel

Like China, India remains a big domestic market, which will continue to attract investment, but the US tariffs will make India unattractive for future investments.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Was Pahalgam a trap by Pakistan to lure India into a conflict? An Army officer thinks so

Speaking at tri-service seminar, Major General SP Vishwasrao also said farmers’ protest, anti-CAA agitation & situation in Manipur was part of ‘larger ploy’ to destabilise India.

That Oval Office picture for ages deserves closer Indian reading, with a geopolitical lens

Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.